NCT05040347View on ClinicalTrials.gov

Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

August 18, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Neutrophil Extracellular Trap FormationPortal Vein Tumor Thrombosis
Interventions
OTHER

test NETs markers

NETs markers (Myeloperoxidase, Neutrophil elastase, Citrate histone H3) and anti-β2 glycoprotein I were detected in plasma using capture ELISA and specific ELISA kits.

Trial Locations (1)

Unknown

the Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT05040347 - Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter